A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients
Clinical trial NCT01588769 · COMPLETED
Trial details
- NCT number
- NCT01588769
- Sponsor
- CytoVac A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-11-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.